The Problems of Applying Classical Pharmacology Analysis to Modern In Vitro Drug Discovery Assays: Slow Binding Kinetics and High Target Concentration
| Autor: | Sam R J Hoare |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Kinetics Computational biology In Vitro Techniques Ligands Biochemistry Analytical Chemistry 03 medical and health sciences 0302 clinical medicine Drug Discovery Humans Potency Bioassay Receptor Pharmacology Chemistry Drug discovery Computational Biology Ligand (biochemistry) In vitro 030104 developmental biology Molecular Medicine Classical pharmacology 030217 neurology & neurosurgery Biotechnology |
| Zdroj: | SLAS Discovery. 26:835-850 |
| ISSN: | 2472-5552 |
| Popis: | The analysis framework used to quantify drug potency in vitro (e.g., Kd or Ki) was initially developed for classical pharmacology bioassays, for example, organ bath experiments testing moderate-affinity natural products. Modern drug discovery can infringe the assumptions of the classical pharmacology analysis equations, owing to the reduction of assay volume in miniaturization, target overexpression, and the increase of compound-target affinity in medicinal chemistry. These assumptions are that (1) the compound concentration greatly exceeds the target concentration (i.e., minimal ligand depletion), and (2) the compound is at equilibrium with the receptor (i.e., rapid ligand binding kinetics). Unappreciated infringement of these assumptions can lead to substantial underestimation of compound affinity, which negatively impacts the drug discovery process, from early-stage lead optimization to prediction of human dosing. This study evaluates the real-world impact of these factors on the target interaction assays used in drug discovery using literature examples, database searches, and simulations. The ranges of compound affinity and the assay types that are prone to depletion and equilibration artifacts are identified. Importantly, the highest-affinity compounds, usually the highest value chemical matter in drug discovery, are the most affected. Methods and simulation tools are provided to enable investigators to evaluate, manage, and minimize depletion or equilibration artifacts. This study enables the correct application of pharmacological data analysis to accurately quantify affinity using modern drug discovery assay technology. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|